Drug Shortage Report for TARO-DASATINIB
Report ID | 173713 |
Drug Identification Number | 02499304 |
Brand name | TARO-DASATINIB |
Common or Proper name | DASATINIB |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | DASATINIB |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 60 |
ATC code | L01EA |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-06-01 |
Estimated end date | 2023-10-06 |
Actual end date | 2023-09-26 |
Shortage status | Resolved |
Updated date | 2023-10-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.